Abstract:In recent years, new-generation high-throughput technologies, including next-generation sequencing technology and mass spectrometry method, have been widely applied in solving biological problems, especially in human diseases field. This data driven, large-scale and industrialized research model enables the omnidirectional and multi-level study of human diseases from the perspectives of genomics, transcriptomics and proteomics levels, etc. In this paper, the latest development of the high-throughput technologies that applied in DNA, RNA, epigenomics, metagenomics including proteomics and some applications in translational medicine are reviewed. At genomics level, exome sequencing has been the hot spot of the recent research. However, the predominance of whole genome resequencing in detecting large structural variants within the whole genome level is coming to stand out as the drop of sequencing cost, which also makes it possible for personalized genome based medicine application. At trancriptomics level, e.g., small RNA sequencing can be used to detect known and predict unknown miRNA. Those small RNA could not only be the biomarkers for disease diagnosis and prognosis, but also show the potential of disease treatment. At proteomics level, e.g., target proteomics can be used to detect the possible disease-related protein or peptides, which can be useful index for clinical staging and typing. Furthermore, the application and development of trans-omics study in disease research are briefly introduced. By applying bioinformatics technologies for integrating multi-omics data, the mechanism, diagnosis and therapy of the disease are likely to be systemically explained and realized, so as to provide powerful tools for disease diagnosis and therapies.

[Whole-genome sequencing: a new approach for understanding of pathogenesis and individualized treatment of cancer].

Genomic Sequencing for Cancer Diagnosis and Therapy.

New-generation high-throughput technologies based 'omics' research strategy in human disease]

Cancer whole-genome sequencing: present and future

[Detection of somatic mutations in deteriorated cell of peritoneal mesothelioma by whole genome sequencing].

Applications of single-cell sequencing in cancer research: progress and perspectives

Unveiling the pan-cancer landscape of S100A16: A comprehensive analysis of prognostic significance, drug sensitivity, and immunomodulatory roles

Single Cell Sequencing: A New Dimension in Cancer Diagnosis and Treatment

Single-cell sequencing technology in tumor research

Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing

Multiple Gene Dysfunctions Lead to High Cancer-Susceptibility: Evidences from a Whole-Exome Sequencing Study.

The Development of Cancer Genome Research and Its Clinical Opportunity Brought by Next Generation Sequencing

Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research

Single-cell multi-omics sequencing and its application in tumor heterogeneity.

Current and future trends in whole genome sequencing in cancer

Whole Genome Sequencing in single CTC improves clinical outcome in Her-2 negative breast cancer patients

Clinical application of whole-genome sequencing for precision oncology of solid tumors

The Application of Single-Cell Sequencing in Pancreatic Neoplasm: Analysis, Diagnosis and Treatment

Whole-exome Sequencing of Tumour-Only Samples Reveals the Association Between Somatic Alterations and Clinical Features in Pancreatic Cancer

Clinical Next Generation Sequencing for Precision Medicine in Cancer

Understanding cervical cancer at single-cell resolution